Business · 25/10/2024
FDA Announces Public Meeting of Pharmacy Compounding Advisory Committee to Discuss Bulk Drug Substances
The Food and Drug Administration (FDA) is hosting a public meeting of the Pharmacy Compounding Advisory Committee to gather input on the nomination of bulk drug substances for inclusion on the Section 503A list, with public comments accepted through an online docket.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →